Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.61 |
| ▸ | THRB | P10828 | 1/20 | 0.61 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.61 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.61 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.61 |
| ▸ | THPO | P40225 | 1/20 | 0.61 |
| ▸ | RECQL | P46063 | 1/20 | 0.61 |
| ▸ | BLM | P54132 | 1/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.59 |
| ▸ | GNPAT | O15228 | 1/20 | 0.57 |
| ▸ | CA2 | P00918 | 3/20 | 0.52 |
| ▸ | CA4 | P22748 | 1/20 | 0.52 |
| ▸ | FNTA | P49354 | 2/20 | 0.46 |
| ▸ | FNTB | P49356 | 2/20 | 0.46 |
| ▸ | MME | P08473 | 4/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| N-Acetylaspartic Acid SCHEMBL31119891 | 1.00 | MAPT (0.61) | MAPTKDM4ETHRBALOX15NFKB1 | |
| N-Acetylaspartic Acid SCHEMBL848463 | 1.00 | MAPT (0.61) | MAPTKDM4ETHRBALOX15NFKB1 | |
| N-Acetylaspartic Acid SCHEMBL163861 | 1.00 | MAPT (0.61) | MAPTKDM4ETHRBALOX15NFKB1 | |
| N-Acetylaspartic Acid SCHEMBL28602698 | 0.98 | MAPT (0.59) | MAPTKDM4ETHRBALOX15NFKB1 | |
| N-Acetylaspartic Acid SCHEMBL27883016 | 0.98 | MAPT (0.59) | MAPTKDM4ETHRBALOX15NFKB1 | |
| N-Acetylaspartic Acid SCHEMBL27980402 | 0.98 | MAPT (0.59) | MAPTKDM4ETHRBALOX15NFKB1 | |
| N-Acetylaspartic Acid SCHEMBL27980404 | 0.98 | MAPT (0.59) | MAPTKDM4ETHRBALOX15NFKB1 | |
| N-Acetylaspartic Acid SCHEMBL27908998 | 0.98 | MAPT (0.59) | MAPTKDM4ETHRBALOX15NFKB1 | |
| N-Acetylaspartic Acid SCHEMBL28715832 | 0.98 | MAPT (0.59) | MAPTKDM4ETHRBALOX15NFKB1 | |
| N-Acetylaspartic Acid SCHEMBL27908423 | 0.98 | MAPT (0.59) | MAPTKDM4ETHRBALOX15NFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3809 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747627-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | Matterworks Inc (US) | 2026-05-27 | — | — | EP | claimed |
| CN-122050706-A | 7T magnetic resonance head and neck tumor radiotherapy response evaluation system | 中国人民解放军空军军医大学 | 2026-05-15 | — | — | CN | claimed |
| CN-122055160-A | Methods of treating seizure activity | 神经元治疗公司 | 2026-05-15 | — | — | CN | claimed |
| EP-3869192-B1 | METHOD FOR QUANTITATIVE DETECTION OF VARIOUS METABOLITES IN BIOLOGICAL SAMPLE | HUMAN METABOLOMICS INST INC (CN) | 2026-05-13 | — | — | EP | claimed |
| CN-122011099-A | N-terminal acetylation modified LMN-NKA polypeptide derivative or pharmaceutically acceptable salt thereof and preparation method thereof | 橡果美健实业投资股份有限公司 | 2026-05-12 | — | — | CN | claimed |
| CN-122012380-A | Application of metabolic small molecule additive in promoting bovine in-vitro embryo development process | 浙江大学 | 2026-05-12 | — | — | CN | claimed |
| US-20260077060-A1 | Methods of Treating or Preventing Amyotrophic Lateral Sclerosis | ROWAN UNIVERSITY (US) | 2026-03-19 | — | — | US | claimed |
| US-20260048104-A1 | METHODS AND COMPOSITIONS FOR TREATING METABOLIC IMBALANCE IN NEURODEGENERATIVE DISEASE | UNIVERSITY OF MASSACHUSETTS (US) | 2026-02-19 | — | — | US | claimed |
| US-20260048146-A1 | METHODS AND COMPOSITIONS FOR TREATING LEUKODYSTROPHIES | BRIDGEBIO GENE THERAPY LLC (US) | 2026-02-19 | — | — | US | claimed |
| EP-4679087-A1 | BIOMARKER AND USE THEREOF | MEIJI CO., LTD (JP) | 2026-01-14 | — | — | EP | claimed |
| US-5519000-A | OLIGOPEPTIDE | CENTECOR, INC. (US) | 1996-05-21 | — | — | US | claimed |
| WO-1995026744-A1 | TUMOR NECROSIS FACTOR INHIBITORS | CENTOCOR, INC. (US) | 1995-10-12 | — | — | WO | claimed |
| WO-1995009174-A1 | ASPARTOACYLASE GENE, PROTEIN, AND METHODS OF SCREENING FOR MUTATIONS ASSOCIATED WITH CANAVAN DISEASE | MIAMI CHILDREN'S HOSPITAL RESEARCH INSTITUTE, INC. (US) | 1995-04-06 | — | — | WO | claimed |
| WO-1993008830-A1 | COMPOUNDS OF BIOAVAILABLE IRON WITH ACYLATED OVOTRANSFERRIN OR WITH ACYLATED HYDROLYSIS DERIVATIVES THEREOF | ITALFARMACO S.P.A. (IT) | 1993-05-13 | — | — | WO | claimed |
| EP-0243322-B1 | COMPOUNDS CONTAINING BIOAVAILABLE IRON, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | MAGIS FARMACEUTICI S.P.A. (IT) | 1992-01-29 | — | — | EP | claimed |
| EP-0415598-A1 | Cosmetic composition | UNILEVER PLC (GB) | 1991-03-06 | — | — | EP | claimed |
| US-4883786-A | CARDIOTROPIC AGENTS | MAGIS FARMACEUTICI SRL (IT) | 1989-11-28 | — | — | US | claimed |
| EP-0167115-B1 | NEW DERIVATIVES OF L-CARNITINE | MAGIS FARMACEUTICI S.P.A. (IT) | 1988-04-20 | — | — | EP | claimed |
| EP-0167115-A2 | New derivatives of L-carnitine | MAGIS FARMACEUTICI S.P.A. (IT) | 1986-01-08 | — | — | EP | claimed |
| US-4175084-A | AND AN N-ACYL ASPARTIC ACID CARRIER, FOR PSYCHOLOGICAL DISORDERS, LEARNING ENHANCEMENT AND SLEEP INDUCTION | SENTRALINSTITUTT FOR INDUSTRIELL FORSKNING (NO) | 1979-11-20 | — | — | US | claimed |